Olink shares are falling after the British antitrust authority begins a review of its deal with Thermo Fisher

Thermo Fisher Science Office in Whitby, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Olink Holding (NASDAQ:OLK) decreased by 1.7% after the UK antitrust regulator launched a formal investigation into the company’s proposed sale to Thermo Fisher for $3.1 billion (NYSE:TMO).

According to the published entry, the British Competition and Markets Authority has started the first stage of the merger review